In its complaint filed Jan. 26, federal prosecutors allege that WeCare Pharmacy, its pharmacist owner Qingping Zhan and pharmacy technician Li Yang regularly participated in opioid dispensing practices that violate the Controlled Substances Act.
According to the complaint, prescriptions dispensed by the defendants were often for highly addictive opioids like oxycodone and hydromorphone, and they were almost always written for the highest-strength formulations available. It also alleges that they consistently filled prescriptions written by a particular physician without taking “corresponding responsibility [that] rests with the pharmacist who fills the prescription.”
More articles on opioids:
Former Insys Therapeutics CEO to pay $5M for alleged improper opioid marketing
Walmart pharmacists warned for years about potentially illegal opioid sales, report finds
License revoked for Florida physician accused of inappropriately prescribing opioids, asking patient for $35K
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.